ArticleFrontiers in endocrinology2026
Widefield SS-OCTA-detected retinal vascular changes and their correlation with DME in diabetes.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study investigated retinal blood flow alterations in diabetic macular edema (DME) using ultra-widefield optical coherence tomography angiography (OCTA). Methods: We enrolled 31 healthy controls (NC, 56 eyes), 40 diabetes patients without diabetic retinopathy (DM, 79 eyes), 25 non-proliferative diabetic retinopathy patients (NPDR, 47 eyes), and 42 DME patients (DME, 54 eyes). OCTA images were analyzed using five-quadrant and concentric zonal divisions to assess vascular density (VD) in the superficial (SVC) and deep vascular complexes (DVC). Results: In the DM group, nasal SVC VD was significantly reduced in the N11, N16, and N21 regions. NPDR patients showed widespread SVC VD reduction compared to controls and DM patients, while DME patients exhibited elevated SVC VD in the peripheral retina (11-21 mm). DVC changes were significant only in the macular area in NPDR group, with DME patients showing increased VD in all regions except I21. Peripheral DVC VD (T11, T16, S16) strongly correlated with DME on ROC analysis. Conclusions: Nasal SVC vascular alterations are among the detectable early intergroup differences in preclinical DR, and peripheral DVC VD is closely correlated with the presence of DME.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.